Skip to main content
. 2019 Dec 6;59(7):941–944. doi: 10.2169/internalmedicine.3824-19

Table.

Clinical Characteristics of Three Children with Chronic Hepatitis C Virus (HCV) Genotype 1b Infection.

Case 1 Case 2 Case 3
Age 10y7m 13y11m 10y8m
Sex Female Female Female
Body height (m) 1.42 1.51 1.37
Body weight (kg) 48.9 38.0 30.9
History of anti-HCV therapy No No No
Leukocyte count (/mm3) 7,480 5,260 8,720
Hemoglobin (g/dL) 13.9 13.1 13.8
Platelet count (×104/µL) 24.6 25.4 35.9
Prothrombin activity (%) 98 97 97
Total bilirubin (mg/dL) 0.7 1.1 0.5
Aspartate aminotransferase (U/L) 38 18 33
Alanine aminotransferase (U/L) 52 20 19
Albumin (g/dL) 4.2 4.3 4.7
Alpha-fetoprotein (ng/mL) 0.9 2.2 1.6
FIB4 index 0.22 0.21 0.22
Fibroscan (kPa) 5.3 3.7 3.0
HCV genotype in children 1b 1b 1b
HCV genotype in mothers 1b 1b 1b
HCV RNA (log IU/mL) 5.2 4.9 5.2
NS3-D168 Wild Wild Wild
NS5A-L31 Wild Mix (L>>I/V) Wild
NS5A-Y93 Wild Wild Wild
Regimens of DAAs OBV+PTV/r OBV+PTV/r GLE+PIB
Doses of DAAs OBV 25 mg OBV 25 mg GLE 300 mg
PTV 150 mg PTV 150 mg PIB 120 mg
r 100 mg r 100 mg

OBV+PTV/r: ombitasvir+paritaprevir/ritonavir, GLE+PIB: glecaprevir+pibrentasvir